Lawyers Backtrack: Mangione Drops Psychiatric Defence in State Murder Trial
Luigi Mangione’s legal team announced that it would no longer pursue a psychiatric defence in the state murder case, following a brief announcement the day before they had told the court they would demonstrate that the defendant suffered from “extreme emotional disturbance” at the time of the shooting.
The lawyer’s reversal was made just before a Thursday deadline requiring the attorneys to provide the Manhattan district attorney’s office with supporting information for a psychiatric strategy. Had the defence been accepted, Mangione could have been convicted of manslaughter rather than murder, potentially leading to a reduced prison term. A psychiatric defence, in this context, would admit that the shooting occurred under mitigating circumstances, whereas a plea of not guilty by reason of insanity typically seeks full exoneration and psychiatric treatment.
Mangione, who is 28, remains in custody after pleading not guilty in both federal and state proceedings. The federal case also carries stalking allegations that could, if proven, lead to a maximum sentence of life in prison.
The murder stemmed from an incident on 4 December 2024 when UnitedHealthcare chief executive Brian Thompson was shot from behind as he entered a Manhattan hotel for an investor conference. Mangione was arrested a few days later.
His next court appearance is scheduled for 11 August, before the state trial set for 8 September. The Manhattan district attorney’s office declined to comment on the attorneys’ decision.
For real‑time updates on this case and other breaking news, tune into PulseWire’s live coverage and join the discussion on our social feeds.
